These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31494282)

  • 1. Friedreich ataxia- pathogenesis and implications for therapies.
    Delatycki MB; Bidichandani SI
    Neurobiol Dis; 2019 Dec; 132():104606. PubMed ID: 31494282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiogical and therapeutic progress in Friedreich ataxia.
    Puccio H; Anheim M; Tranchant C
    Rev Neurol (Paris); 2014 May; 170(5):355-65. PubMed ID: 24792433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friedreich Ataxia: From the Eye of a Molecular Biologist.
    Muthuswamy S; Agarwal S
    Neurologist; 2015 Sep; 20(3):51-5. PubMed ID: 26375377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
    Medina-Carbonero M; Sanz-Alcázar A; Britti E; Delaspre F; Cabiscol E; Ros J; Tamarit J
    Cell Mol Life Sci; 2022 Jan; 79(2):74. PubMed ID: 35038030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia.
    Gottesfeld JM
    Neurotherapeutics; 2019 Oct; 16(4):1032-1049. PubMed ID: 31317428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Pathophysiology in Friedreich's Ataxia.
    Li K
    Adv Exp Med Biol; 2019; 1173():125-143. PubMed ID: 31456208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules affecting transcription in Friedreich ataxia.
    Gottesfeld JM
    Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic developments in Friedreich ataxia.
    Wilson RB
    J Child Neurol; 2012 Sep; 27(9):1212-6. PubMed ID: 22791549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.
    Galea CA; Huq A; Lockhart PJ; Tai G; Corben LA; Yiu EM; Gurrin LC; Lynch DR; Gelbard S; Durr A; Pousset F; Parkinson M; Labrum R; Giunti P; Perlman SL; Delatycki MB; Evans-Galea MV
    Ann Neurol; 2016 Mar; 79(3):485-95. PubMed ID: 26704351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
    Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
    Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of Friedreich ataxia: a European perspective.
    Schulz JB; Boesch S; Bürk K; Dürr A; Giunti P; Mariotti C; Pousset F; Schöls L; Vankan P; Pandolfo M
    Nat Rev Neurol; 2009 Apr; 5(4):222-34. PubMed ID: 19347027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review).
    Palau F
    Int J Mol Med; 2001 Jun; 7(6):581-9. PubMed ID: 11351269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the molecular pathogenesis of Friedreich ataxia.
    Puccio H; Koenig M
    Hum Mol Genet; 2000 Apr; 9(6):887-92. PubMed ID: 10767311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's ataxia.
    Alper G; Narayanan V
    Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.
    Santos R; Lefevre S; Sliwa D; Seguin A; Camadro JM; Lesuisse E
    Antioxid Redox Signal; 2010 Sep; 13(5):651-90. PubMed ID: 20156111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.
    Pandolfo M
    Blood Cells Mol Dis; 2002; 29(3):536-47; discussion 548-52. PubMed ID: 12547248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friedreich ataxia: an overview.
    Delatycki MB; Williamson R; Forrest SM
    J Med Genet; 2000 Jan; 37(1):1-8. PubMed ID: 10633128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich ataxia.
    Pandolfo M
    Semin Pediatr Neurol; 2003 Sep; 10(3):163-72. PubMed ID: 14653404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy.
    Lynch DR; Farmer JM; Balcer LJ; Wilson RB
    Arch Neurol; 2002 May; 59(5):743-7. PubMed ID: 12020255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.